Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ORBITA-CTO Pilot: A Comparison of the Impact of CTO PCI Versus Placebo on Angina in Patients With Background Optimal Medical Therapy - a Pilot Study

NCT05142215 is registered in ClinicalTrials.gov with Mid and South Essex NHS Foundation Trust as lead sponsor.

NCT NCT05142215
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05142215 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ORBITA-CTO Pilot: A Comparison of the Impact of CTO PCI Versus Placebo on Angina in Patients With Background Optimal Medical Therapy - a Pilot Study
Lead sponsor
Mid and South Essex NHS Foundation Trust
Phase
Not applicable
Overall status
Completed
Start date
October 19, 2021
Completion date
October 21, 2025
Enrollment
50 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

chronic total occlusion of coronary artery, stable angina